Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 4 Weeks

04-Mar-22 - 31-Mar-22
Buy Ratio:32%

Up

# Net Buyers:8
# Net Sellers:17

Previous 4 Weeks

04-Feb-22 - 03-Mar-22
Buy Ratio:30%
# Net Buyers:13
# Net Sellers:30
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Abbott Laboratories--$14.69M  
Armata Pharmaceuticals, Inc.$26.93M$8.85M  
Humanigen, Inc$3.00M$3.00M  
Regeneron Pharmaceuticals, Inc.--$2.84M  
Exelixis, Inc.--$2.44M  
New Net Buyers
CompanyNet Buy AmountChange
Alkermes Plc.$10.00K$364.70K  
Incyte Corp$86.96K$165.54K  
Surmodics Inc$17.86K$49.61K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Eli Lilly & Co($162.20M)($197.36M)  
Amgen Inc($8.60M)($8.60M)  
Johnson & Johnson($4.17M)($4.17M)  
Charles River Laboratories International, Inc.--($3.75M)  
Myriad Genetics Inc($1.71M)($1.61M)  
New Net Sellers
CompanyNet Buy AmountChange
Eli Lilly & Co($162.20M)($197.36M)  
Bausch Health Companies Inc.($39.94K)($901.05K)